Phospholamban As a Crucial Determinant of the Inotropic Response of Human Pluripotent Stem Cell-derived Ventricular Cardiomyocytes and Engineered 3-dimensional Tissue Constructs
Overview
Authors
Affiliations
Background: Human (h) embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) serve as a potential unlimited ex vivo source of cardiomyocytes (CMs). However, a well-accepted roadblock has been their immature phenotype. hESC/iPSC-derived ventricular (v) CMs and their engineered cardiac microtissues (hvCMTs) similarly displayed positive chronotropic but null inotropic responses to β-adrenergic stimulation. Given that phospholamban (PLB) is robustly present in adult but poorly expressed in hESC/iPSC-vCMs and its defined biological role in β-adrenergic signaling, we investigated the functional consequences of PLB expression in hESC/iPSC-vCMs and hvCMTs.
Methods And Results: First, we confirmed that PLB protein was differentially expressed in hESC (HES2, H9)- and iPSC-derived and adult vCMs. We then transduced hES2-vCMs with the recombinant adenoviruses (Ad) Ad-PLB or Ad-S16E-PLB to overexpress wild-type PLB or the pseudophosphorylated point-mutated variant, respectively. As anticipated from the inhibitory effect of unphosphorylated PLB on sarco/endoplasmic reticulum Ca2+-ATPase, Ad-PLB transduction significantly attenuated electrically evoked Ca2+ transient amplitude and prolonged the 50% decay time. Importantly, Ad-PLB-transduced hES2-vCMs uniquely responded to isoproterenol. Ad-S16E-PLB-transduced hES2-vCMs displayed an intermediate phenotype. The same trends were observed with H9- and iPSC-vCMs. Directionally, similar results were also seen with Ad-PLB-transduced and Ad-S16E-transduced hvCMTs. However, Ad-PLB altered neither the global transcriptome nor ICa,L, implicating a PLB-specific effect.
Conclusions: Engineered upregulation of PLB expression in hESC/iPSC-vCMs restores a positive inotropic response to β-adrenergic stimulation. These results not only provide a better mechanistic understanding of the immaturity of hESC/iPSC-vCMs but will also lead to improved disease models and transplantable prototypes with adult-like physiological responses.
Seguret M, Davidson P, Robben S, Jouve C, Pereira C, Lelong Q Elife. 2024; 12.
PMID: 38578976 PMC: 11001295. DOI: 10.7554/eLife.87739.
Ernst P, Bidwell P, Dora M, Thomas D, Kamdar F Front Cell Dev Biol. 2023; 10:986107.
PMID: 36742199 PMC: 9889838. DOI: 10.3389/fcell.2022.986107.
Wu P, Sai X, Li Z, Ye X, Jin L, Liu G Bioact Mater. 2022; 20:286-305.
PMID: 35702609 PMC: 9167678. DOI: 10.1016/j.bioactmat.2022.05.024.
Huethorst E, Mortensen P, Simitev R, Gao H, Pohjolainen L, Talman V J Physiol. 2021; 600(3):483-507.
PMID: 34761809 PMC: 9299844. DOI: 10.1113/JP282228.
Revisiting tissue tensegrity: Biomaterial-based approaches to measure forces across length scales.
Boghdady C, Kalashnikov N, Mok S, McCaffrey L, Moraes C APL Bioeng. 2021; 5(4):041501.
PMID: 34632250 PMC: 8487350. DOI: 10.1063/5.0046093.